▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

CopilotIQ and Biofourmis Merge to Create the First End-to-End Platform for AI-Driven In-Home Care

CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, and Biofourmis, a global technology-enabled care delivery company, delivering in-hom...

Business Wire

Merger Establishes a Category of One Company That Can Deliver In-Home Care from Pre-Surgery, to Acute, Post-Acute, and Chronic Care

NASHVILLE, Tenn. & BOSTON: CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, and Biofourmis, a global technology-enabled care delivery company, delivering in-home care solutions serving enterprise healthcare customers, today announced a strategic merger. The combined company creates the industry's first AI-driven platform that delivers in-home care across the full spectrum from pre-surgical optimization to acute, post-acute, and chronic care.

For customers, the combination delivers a single vendor that can provide a best-in-class offering across the entire care continuum and creates a ‘single pane of glass’ solution by which enterprise customers will enjoy observability of patients across the care continuum via one technology integration, one security audit, simplified procurement, and a much better patient experience. Hospitals and payors are struggling with an overwhelming level of complexity and cost to manage multiple point solutions required to deliver the necessary suite of home-based care. This combination provides the first solution that solves these problems.

“Our mission is to redefine the future of healthcare delivery, by extending care to the comfort of patients’ homes, and driving improved health outcomes, at the lowest possible cost to the system,” said David Koretz, CEO of CopilotIQ and Biofourmis, the newly combined entity. “This merger is a major step toward realizing our vision of transforming healthcare from reactive treatment to proactive prevention, and from generalized to deeply personalized, data-driven care.”

Biofourmis’ capabilities in supporting health systems, payors, and life sciences companies’ delivery of complex care for their patients in the home with FDA-cleared algorithms and technology will be expanded further upstream and downstream when combined with CopilotIQ. The combined company will unlock coordinated, convenient, and cost-effective care for patients managing chronic conditions. Further, CopilotIQ’s transformative software suite for driving patient engagement, improving clinician efficiency, and delivering clinical personalization, will be integrated across Biofourmis’ acute and post-acute offerings.

As part of this combination, leading investors from both businesses, including General Atlantic, Openspace Ventures, and Bessemer Venture Partners are investing into the combined business.

About CopilotIQ

CopilotIQ is the creator of the first High Frequency Connected Care platform to transform outcomes for older Americans with chronic conditions. CopilotIQ combines continuous biomarker data, behavioral analytics and US-licensed nursing visits to drive data-driven improvement, coupled with a clinical automation software platform that delivers unprecedented clinical efficiency. The company was named to Fast Company’s list of the World’s Most Innovative Companies of 2024. CopilotIQ is headquartered in Nashville, TN.

About Biofourmis

Biofourmis brings high-quality care and life-changing clinical trials to any person, anywhere. Biofourmis Care enables hospitals, health systems and payors to seamlessly extend care to patients at home across all levels of acuity. Biofourmis Connect streamlines clinical trials with powerful digital capabilities to bring the most effective therapies to market more efficiently. Biofourmis’ data-driven solutions leverage clinical devices, artificial intelligence, and an ecosystem of virtual clinical teams and in-home services to drive quality outcomes, improve operational efficiency, and lower costs.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Dronus gets a strategic investment by Eni Next

Eni's VC company invest in the Italian drone company to develop new solutions for industrial plants monitoring

Technology Reply wins the 2024 Oracle Partner Awards - Europe South Innovation

Oracle recognizes Technology Reply’s ability to develop and deliver pioneering solutions through partnering with Oracle

Most read

Panjaya.ai Unveils BodyTalk: World’s first AI-Powered Dubbing Platform,…

Panjaya.ai, led by former Apple TV and Vimeo executives, has launched BodyTalk, the first AI-driven translation platform designed to address a common…

Glean Named an AI Cool Vendor in the 2024 Gartner Cool Vendors for Digital…

Work AI leader Glean today announced it has been named a Cool Vendor in the 2024 Cool Vendors in Digital Workplace Applications1 report by Gartner, Inc.…

ISG to Assess Procurement Services Worldwide

$III #CategoryManagementServices--Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched…

Spoofing Detection Technologies Market Research Report 2024-2034: Growth…

The "Spoofing Detection Technologies Market - A Global and Regional Analysis: Focus on Application, Solution Type, and Region - Analysis and Forecast,…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!